Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer.
暂无分享,去创建一个
A. Italiano | S. Oudard | G. Gravis | F. Joly | D. Pouessel | K. Fizazi | P. Beuzeboc | J. Ferrero | E. Bompas | C. Ortholan | A. Flechon